Weight Loss and Obesity Management Market Size in 2022, Trends, SWOT analysis, Rapid growth Forecast to 2028

Report OverviewDue to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Weight Loss and Obesity Management estimated at USD million in the year 2022, is projected to reach a revised size of USD million by 2028, growing at a CAGR of percent during the forecast period 2022-2028.The USA market for Weight Loss and Obesity Management is estimated to increase from USD million in 2022 to reach USD million by 2028, at a CAGR of percent during the forecast period of 2023 through 2028.The China market for Weight Loss and Obesity Management is estimated to increase from USD million in 2022 to reach USD million by 2028, at a CAGR of percent during the forecast period of 2023 through 2028.The Europe market for Weight Loss and Obesity Management is estimated to increase from USD million in 2022 to reach USD million by 2028, at a CAGR of percent during the forecast period of 2023 through 2028.The global key companies of Weight Loss and Obesity Management include Novo Nordisk, GlaxoSmithKline, Roche, Allergan, Johnson & Johnson, Medtronic, Vivus Inc, Eisai and Nalpropion Pharmaceuticals, etc. In 2021, the global top five players had a share approximately percent in terms of revenue.